Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 21, 2018
[What is the best management for a spermatic cord sarcoma in 2018?]
S Carrère, R Tetreau, C Honoré, et al.
British Journal of Cancer
|
July 29, 2010
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis
A Dufresne, F Bertucci, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 26, 2010
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck
R Mesía, F Rivera, A Kawecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
N Penel, A Le Cesne, B N Bui, et al.
Acta Gastro-Enterologica Belgica
|
March 22, 2018
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma group
A de Nonneville, C Toullec, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial
B Bui-Nguyen, I Ray-Coquard, C Chevreau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]
F Mornex, L Thomas, P Mohr, et al.
British Journal of Cancer
|
August 11, 2011
Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck
J M Del Campo, R Hitt, P Sebastian, et al.
Melanoma Research
|
February 6, 2003
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma
F Mornex, L Thomas, P Mohr, et al.
Annales De Dermatologie Et De Venereologie
|
February 11, 2014
[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute]
M-T Leccia, F Planchamp, B Sassolas, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 21, 2018
[What is the best management for a spermatic cord sarcoma in 2018?]
S Carrère, R Tetreau, C Honoré, et al.
British Journal of Cancer
|
July 29, 2010
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis
A Dufresne, F Bertucci, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 26, 2010
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck
R Mesía, F Rivera, A Kawecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
N Penel, A Le Cesne, B N Bui, et al.
Acta Gastro-Enterologica Belgica
|
March 22, 2018
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma group
A de Nonneville, C Toullec, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial
B Bui-Nguyen, I Ray-Coquard, C Chevreau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
March 22, 2003
[Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]
F Mornex, L Thomas, P Mohr, et al.
British Journal of Cancer
|
August 11, 2011
Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck
J M Del Campo, R Hitt, P Sebastian, et al.
Melanoma Research
|
February 6, 2003
A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma
F Mornex, L Thomas, P Mohr, et al.
Annales De Dermatologie Et De Venereologie
|
February 11, 2014
[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute]
M-T Leccia, F Planchamp, B Sassolas, et al.
Page
of 8